AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21364503
Drug: Flurbiprofen axetil
RxNorm normalized name: Flurbiprofen axetil
DrugBank: Flurbiprofen axetil (DB14938)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen axetil 50 mg
Trial: 15911461
Drug: Clomiphene plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene plus Metformin
Trial: 10087798
Drug: Autogenic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autogenic therapy
Trial: 3102275
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate 2 mg
Trial: 3102275
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate 10 mg
Trial: 3102275
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate 20 mg
Trial: 12616672
Drug: Rofecoxib (250.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (250.0 mg/day for 14 days)
Trial: 9794089
Drug: Magnesium orotate
RxNorm normalized name: Magnesium orotate
DrugBank: Magnesium orotate (DB13786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium orotate 3 x 1 g
Trial: 21099129
Drug: Long-acting octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting octreotide treatment for 3 months before surgery
Trial: 21099129
Drug: Long-acting octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting octreotide treatment
Trial: 16700996
Drug: Head hypothermia
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Head hypothermia treatment
Trial: 11250719
Drug: Luteinizing hormone-releasing
RxNorm normalized name: (6-D-Tryptophan)luteinizing hormone-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luteinizing hormone-releasing hormone (LHRH) agonists with low-dose hormone replacement
Trial: 29485324
Drug: Protein Supplement
RxNorm normalized name: PROTEIN SUPPLEMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein Supplement (PRO, 42 g/serving)
Trial: 27243611
Drug: Daily music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily music training for 28 days
Trial: 22288685
Drug: Four-dose hydrocortisone
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-dose hydrocortisone regimen (10 + 10 + 5 + 5 mg)
Trial: 22288685
Drug: Two-dose hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose hydrocortisone regimen (20 + 0 + 10 + 0 mg)
Trial: 18478944
Drug: Sufentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil at 0.3 ng/ml with nitrogen monoxide inhalation at 0.9 MAC
Trial: 18478944
Drug: Sufentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil at 0.4 ng/ml with nitrogen monoxide inhalation at 0.9 MAC
Trial: 18478944
Drug: Sufentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil at 0.5 ng/ml with nitrogen monoxide inhalation at 0.9 MAC
Trial: 15560968
Drug: Ketamine (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.6 mg/kg/h)
Trial: 12084590
Drug: Intracoronary radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary radiation therapy (IRT)
Trial: 8524979
Drug: Clonidine (CLO)
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine (CLO) at doses of 1.5 micrograms/kg and 2.5 micrograms/kg
Trial: 8524979
Drug: Diazepam (DZP)
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam (DZP) at doses of 5 mg and 10 mg
Trial: 2405171
Drug: Postoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiotherapy (total mean dose of 54 Gy to the breast)
Trial: 2405171
Drug: Surgery alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery alone (no further treatment)
Trial: 415321
Drug: Marijuana (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana (0.7 mg/kg delta‐9‐tetrahydrocannabinol)
Trial: 415321
Drug: Ethanol (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (1.0 ml/kg 95% ethanol)
Trial: 30165156
Drug: 80% reduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80% reduction of basal insulin applied 40 minutes before exercise (T-40)
Trial: 30165156
Drug: 80% reduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80% reduction of basal insulin applied 20 minutes before exercise (T-20)
Trial: 30165156
Drug: 80% reduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80% reduction of basal insulin applied at exercise onset (T0)
Trial: 21771987
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus triptorelin (3.75 mg intramuscularly at least 1 week before chemotherapy and then every 4 weeks during chemotherapy)
Trial: 16766776
Drug: BCAA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA supplementation (12 g of BCAAs/day; leucine 54%, isoleucine 19%, valine 27%)
Trial: 16766776
Drug: Placebo (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (12 g of glucose/day)
Trial: 9250944
Drug: Ketamine psychedelic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine psychedelic therapy (KPT)
Trial: 8222534
Drug: PGE1 infusion
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE1 infusion (20-30 ng kg-1 min)
Trial: 3929876
Drug: Feverfew capsules
RxNorm normalized name: FEVERFEW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feverfew capsules (freeze dried powder)
Trial: 31337448
Drug: Protein supplementation
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein supplementation (27.5 g whey protein/d, about 2000 kJ/d)
Trial: 31337448
Drug: Isoenergetic placebo-products
RxNorm normalized name: placebo Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoenergetic placebo-products (< 1.5 g protein/d)
Trial: 26693964
Drug: STAR intervention
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STAR intervention (Supporting Treatment Adherence Regimens)
Trial: 20580358
Drug: Recombinant hCG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hCG (250 μg)
Trial: 19464177
Drug: Fulvestrant (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulvestrant (250 mg/month)
Trial: 17673609
Drug: Fulvestrant high-dose
RxNorm normalized name: Fulvestrant
DrugBank: Fulvestrant (DB00947)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fulvestrant high-dose (500 mg/month)
Trial: 17673609
Drug: Fulvestrant loading-dose
RxNorm normalized name: Fulvestrant
DrugBank: Fulvestrant (DB00947)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fulvestrant loading-dose regimen (250 mg/month plus 500 mg on day 0 and 250 mg on day 14 of month 1)
Trial: 16051400
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of pertussis vaccine
Trial: 16051400
Drug: Third dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third dose of pertussis vaccine
Trial: 11966926
Drug: Subgingival water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgingival water irrigation 2x daily
Trial: 10080558
Drug: Fananserin 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fananserin 250 mg b.i.d. over 28 days (with an 8-day escalation)
Trial: 7018502
Drug: Colestipol (15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol (15, 20, and 30 g/day)
Trial: 230927
Drug: Clofibrate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofibrate (2 g/day)
Trial: 22423411
Drug: Orthodontic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic treatment alone
Trial: 22423411
Drug: Orthodontic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic treatment combined with orthognathic surgery
Trial: 22423411
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (orthodontic treatment alone)
Trial: 12297762
Drug: Somatostatin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin (750 mg)
Trial: 12297762
Drug: Gabexate (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabexate (500 mg)
Trial: 2148357
Drug: Fosinopril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril (5 to 40 mg/day)
Trial: 29931409
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg three times daily
Trial: 20428949
Drug: Prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 2 mg and 4 mg
Trial: 18322858
Drug: modafinil 400
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: modafinil 400 mg
Trial: 18322858
Drug: dextroamphetamine 20
RxNorm normalized name: dextroamphetamine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dextroamphetamine 20 mg
Trial: 18322858
Drug: caffeine 600
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: caffeine 600 mg
Trial: 12943873
Drug: Gemcabene 150
RxNorm normalized name: Gemcabene
DrugBank: Gemcabene (DB05123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcabene 150 mg
Trial: 12943873
Drug: Gemcabene 600
RxNorm normalized name: Gemcabene
DrugBank: Gemcabene (DB05123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcabene 600 mg
Trial: 1707149
Drug: Diphenhydramine syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine syrup plus kaolin-pectin
Trial: 6809324
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous hyperalimentation (Control group)
Trial: 23311732
Drug: ACT-178882 300
RxNorm normalized name: ACT-541468
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACT-178882 300 mg single-dose
Trial: 23311732
Drug: ACT-178882 300
RxNorm normalized name: ACT-541468
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACT-178882 300 or 600 mg multiple-dose
Trial: 23311732
Drug: ACT-178882 multiple-dose
RxNorm normalized name: ACT-541468
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACT-178882 multiple-dose
Trial: 21333466
Drug: Baclofen (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (80 mg/day)
Trial: 17643781
Drug: Photoprotection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photoprotection of total parenteral nutrition (TPN)
Trial: 17643781
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) without photoprotection
Trial: 15753144
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg RRR‐alpha‐tocopheryl acetate
Trial: 15753144
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg all‐rac‐alpha‐tocopheryl acetate
Trial: 11727359
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - 0.625 mg 17 beta‐estradiol plus 10 mg progestin, followed for 48 months
Trial: 3367677
Drug: Low-energy helium-neon
RxNorm normalized name: neon
DrugBank: Neon (DB11589)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy helium-neon (HeNe) laser irradiation (0.9 mW) for 60 seconds daily over a 5-day period.
Trial: 26440227
Drug: Ticagrelor 180
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 180 mg loading dose (LD)/90 mg twice‐daily maintenance dose (MD)
Trial: 26440227
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg LD/75 mg once‐daily MD
Trial: 9522323
Drug: 17 beta‐estradiol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 2.5 mg
Trial: 9522323
Drug: 17 beta‐estradiol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 5 mg
Trial: 9522323
Drug: 17 beta‐estradiol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 10 mg
Trial: 9522323
Drug: 17 beta‐estradiol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 15 mg
Trial: 29359385
Drug: Focused ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focused ultrasound device (UltraShape) treatment on one thigh
Trial: 12146536
Drug: Subantimicrobial dose
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subantimicrobial dose doxycycline (SDD)
Trial: 17061750
Drug: Dietary soy
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary soy supplement
Trial: 11205485
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention (ad libitum diet low in animal fat and refined carbohydrates, rich in low-glycemic-index foods, monounsaturated and n-3 polyunsaturated fatty acids, and phytoestrogens) with intensive dietary counseling and specially prepared group meals twice a week over 4.5 months.
Trial: 7722994
Drug: Validated and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Validated and improved alcoholism treatment methods from Project MATCH and other studies
Trial: 25722291
Drug: CC‐H5N1 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC‐H5N1 vaccine (3.75 µg of hemagglutinin antigen with AS03 adjuvant)
Trial: 25722291
Drug: CC‐H5N1 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC‐H5N1 vaccine (1.9 µg of hemagglutinin antigen with AS03 adjuvant)
Trial: 25722291
Drug: Embryonated-egg-derived vaccine
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Embryonated-egg-derived vaccine (3.75 µg of HA with AS03)
Trial: 25722291
Drug: Embryonated-egg-derived vaccine
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Embryonated-egg-derived vaccine (15 µg of plain HA)
Trial: 19016202
Drug: Intravenous moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous moxifloxacin plus intravitreal 1 mg Vancomycin plus 2.25 mg Ceftazidim
Trial: 19016202
Drug: Intravenous moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous moxifloxacin only
Trial: 12568412
Drug: Cal+D-group (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cal+D-group (1200 mg calcium plus 800 IU cholecalciferol)
Trial: 12568412
Drug: Cal-group (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cal-group (1200 mg calcium)
Trial: 10738705
Drug: Total dust
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total dust exposure (2.4 mg/m3)
Trial: 10738705
Drug: Respirable dust
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respirable dust exposure (0.16 mg/m3)
Trial: 1405327
Drug: ANF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ANF (5 pmol/kg/min) with prazosin (0.25 mg)
Trial: 1405327
Drug: Prazosin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (0.25 mg)
Trial: 29133954
Drug: Intravenous ghrelin
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ghrelin (3 mcg kg−1 loading dose followed by 16.9 ng/kg/min infusion)
Trial: 29133954
Drug: Intravenous ghrelin
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ghrelin
Trial: 21144850
Drug: Esomeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (20 mg/day) + Clopidogrel (75 mg/day)
Trial: 21144850
Drug: Clopidogrel alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel alone (75 mg/day)
Trial: 3317340
Drug: Captopril (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50-100 mg/day)
Trial: 3317340
Drug: Verapamil (160-240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (160-240 mg/day)
Trial: 7027178
Drug: Acyclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (ACV) 3% ointment
Trial: 7027178
Drug: Idoxuridine (IDU)
RxNorm normalized name: Idoxuridine
DrugBank: Idoxuridine (DB00249)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Idoxuridine (IDU) 0.5% ointment
Trial: 28070653
Drug: Phenylephrine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine infusion at 0.5 µg/kg/min during induction of anesthesia
Trial: 28070653
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no phenylephrine infusion)
Trial: 21992003
Drug: metoprolol 50
RxNorm normalized name: metoprolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 50 mg
Trial: 21992003
Drug: metoprolol 25
RxNorm normalized name: metoprolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 25 mg
Trial: 3311661
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg cisapride administered tid for three days
Trial: 3311661
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cisapride administered tid for three days
Trial: 26756988
Drug: Internet-administered questionnaires
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-administered questionnaires (SRS-30 and PODCI)
Trial: 26756988
Drug: Pen and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pen and paper-administered questionnaires (SRS-30 and PODCI)
Trial: 26756988
Drug: Paper-administered questionnaires
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper-administered questionnaires (SRS-30 and PODCI)
Trial: 21366030
Drug: Abdominal massage
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal massage with prescribed laxatives
Trial: 21366030
Drug: Prescribed laxatives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescribed laxatives only
Trial: 18651540
Drug: Ibandronate 2
RxNorm normalized name: ibandronate 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 2 mg every 4 weeks for 48 weeks
Trial: 19608831
Drug: Inhaled anesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled anesthetic technique using desflurane (DES)
Trial: 15476159
Drug: 2-dose recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose recombinant HBV vaccination
Trial: 15476159
Drug: 3-dose recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-dose recombinant HBV vaccination
Trial: 15476159
Drug: 3-dose plasma-derived
RxNorm normalized name: c1-inhibitor, plasma derived
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-dose plasma-derived HBV vaccination
Trial: 15476159
Drug: 3-dose regimens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-dose regimens (both recombinant and plasma-derived)
Trial: 11448901
Drug: Thalidomide (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (low-dose arm, 200 mg/day)
Trial: 11448901
Drug: Thalidomide (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (high-dose arm, escalated from 200 mg/day to 1200 mg/day)
Trial: 9706917
Drug: HBOC‐201 (Study
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBOC‐201 (Study A: 6.9 mL/kg; Study B: 9.2 mL/kg)
Trial: 2679035
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine at an initial rate of 3 micrograms/kg/min
Trial: 2679035
Drug: Intravenous nitroprusside
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nitroprusside at an initial rate of 1 microgram/kg/min
Trial: 905083
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (treatment)
Trial: 19726772
Drug: Fluvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (80 mg extended-release once daily)
Trial: 7880985
Drug: Sucralphate suspension
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralphate suspension (1 g/5 ml)
Trial: 7880985
Drug: Sucralphate tablet
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralphate tablet (1 g)
Trial: 2740067
Drug: Metoclopramide in
RxNorm normalized name: metoclopramide Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide in combination with low-dose chlorpromazine and high-dose hydrocortisone (regimen B)
Trial: 31564831
Drug: IR‐ESO (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR‐ESO (esomeprazole 20 mg/sodium bicarbonate 800 mg)
Trial: 31564831
Drug: ESO (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESO (esomeprazole 20 mg)